Spots Global Cancer Trial Database for plasma cell dyscrasia

Every month we try and update this database with for plasma cell dyscrasia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Study title	NCT ID	Conditions	Interventions	Eligibility	Organization
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma	NCT00821249	Multiple Myelom... Plasma Cell Leu...	ARRY-520, KSP(E... Filgrastim, gra... Dexamethasone, ...	18 Years -	Pfizer
Companion for CAR-T Web App During Chimeric Antigen Receptor T-cell Therapy	NCT05362331	Lymphoma Leukemia Plasma Cell Dys...	Web Application	18 Years -	University of California, San Francisco
Stem Cell Transplant for Patients With Blood Malignancy Using Donors and Less Toxic Chemotherapy With CAMPATH 1H	NCT00048412	Myelodysplastic... Leukemia Multiple Myelom... Plasma Cell Dys... Lymphoprolifera...	FLUDARABINE CAMPATH 1H FK50 Stem Cell Colle...	- 70 Years	Baylor College of Medicine
A Diagnostic Screening Trial Seeking AL Amyloidosis Very Early	NCT02741999	Plasma Cell Dys... Monoclonal Gamm...		18 Years - 99 Years	Tufts Medical Center
Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or Thalidomide in Myeloma	NCT02155634	Multiple Myelom... Neoplasms Plasma Cells Paraproteinemia... Blood Protein D... Hematologic Dis... Therapeutic Use...	Lenalidomide	18 Years -	Celgene
A Study of ARRY-520 in Patients With Relapsed or Refractory Multiple Myeloma	NCT00821249	Multiple Myelom... Plasma Cell Leu...	ARRY-520, KSP(E... Filgrastim, gra... Dexamethasone, ...	18 Years -	Pfizer
Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)	NCT00579111	Myelodysplastic... Acute Myelogeno... Acute Lymphobla... Chronic Myeloge... Multiple Myelom... Plasma Cell Dys... Lymphoprolifera... Hematologic Dis...	Campath Busulfan Fludarabine Hematopoietic s... FK-506	- 70 Years	Baylor College of Medicine
Pilot Trial of Homebound Stem Cell Transplantation	NCT02671448	Plasma Cell Dys...	Home monitoring... Patient Reporte... Caregiver Repor...	18 Years - 80 Years	Memorial Sloan Kettering Cancer Center
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma	NCT01248923	Multiple Myelom...	ARRY-520, KSP(E... Bortezomib, pro... Dexamethasone, ... Filgrastim, gra... ARRY-520, KSP(E... Bortezomib, pro... Filgrastim, gra...	18 Years -	Array BioPharma
Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies	NCT02556931	Myelodysplastic... Chronic Myelomo... Small Lymphocyt... Chronic Lymphoc... Prolymphocytic ... Chronic Myeloid... Chronic Myelopr... Multiple Myelom... Plasma Cell Neo... Plasma Cell Dys... Myelofibrosis Polycythemia Ve... Essential Throm... Plasma Cell Leu...	Fludarabine Cyclophosphamid... Total body irra... Tacrolimus Mycophenolate m...	-	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A Study of ARRY-520 and Bortezomib Plus Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma	NCT01248923	Multiple Myelom...	ARRY-520, KSP(E... Bortezomib, pro... Dexamethasone, ... Filgrastim, gra... ARRY-520, KSP(E... Bortezomib, pro... Filgrastim, gra...	18 Years -	Array BioPharma
Autologous Stem Cell Transplantation for Patients With AL Amyloidosis	NCT04210791	AL Amyloidosis Plasma Cell Dys...		18 Years - 75 Years	Nanjing University School of Medicine
A Study to Evaluate the Efficacy and Safety of CAEL-101 in Patients With Mayo Stage IIIb AL Amyloidosis	NCT04504825	AL Amyloidosis	CAEL-101 Placebo cyclophosphamid...	18 Years -	Alexion Pharmaceuticals, Inc.
Integrated Cancer Repository for Cancer Research	NCT02012699	Pancreatic Canc... Thyroid Cancer Lung Cancer Esophageal Canc... Thymus Cancer Colon Cancer Rectal Cancer Gastrointestina... Anal Cancer Bile Duct Cance... Duodenal Cancer Gallbladder Can... Gastric Cancer Liver Cancer Small Intestine... Peritoneal Surf... Familial Adenom... Lynch Syndrome Bladder Cancer Kidney Cancer Penile Cancer Prostate Cancer Testicular Canc... Ureter Cancer Urethral Cancer Hypopharyngeal ... Laryngeal Cance... Lip Cancer Oral Cavity Can... Nasopharyngeal ... Oropharyngeal C... Paranasal Sinus... Nasal Cavity Ca... Salivary Gland ... Skin Cancer Central Nervous... Central Nervous... Mesothelioma Breast Cancer Leukemia Melanoma Sarcoma Unknown Primary... Multiple Myelom... Ovarian Cancer Endometrial Can... Vaginal Cancer Neuroendocrine ... Plasma Cell Dys... Healthy Control		19 Years - 110 Years	University of Nebraska

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

Join others from around the world: